Physician profile
Zev Ash
NPI 1770601585
$1,624.83
in general payments reported to CMS, 2019-2025
18 companies · $273 in 2025
The $273 reported for 2025 was more than what 82% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $191 · 2021: $321 · 2022: $262 · 2023: $290 · 2024: $149 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $258.71 | 2021-2023 | Qelbree |
| Glaxosmithkline, LLC. | $247.27 | 2019-2024 | Bexsero |
| Corium, LLC | $218.71 | 2022-2025 | Azstarys |
| Alk-Abello, INC | $165.29 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Takeda Pharmaceuticals U.S.A., INC. | $134.57 | 2020-2021 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $77.67 | 2025 | Relexxii |
| Cranial Technologies, INC | $74.36 | 2021-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $62.59 | 2025 | Jornay Pm |
| Seqirus USA INC | $59.89 | 2022-2025 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi Pasteur INC. | $45.94 | 2021-2022 | |
| Kaleo, INC. | $27.60 | 2023 | Auvi-Q |
| Pfizer INC. | $24.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.08 | 2024 | |
| Genentech USA, INC. | $22.27 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $21.38 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $19.79 | 2024 | Vaxneuvance, Gardasil, Vaqta |
| Lnhc, INC | $16.22 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zev Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.